Surgical Treatment for T4 Non-small Cell Lung Cancer Invading Mediastinal Structures.
- Author:
Eun Gu HWANG
1
;
HeeJong BAEK
;
Hae Won LEE
;
Jin Haeng CHUNG
;
Jong Ho PARK
;
Jae Ill ZO
;
Young Mog SHIM
Author Information
1. Department of Thoracic & Cardiovascular Surgery, College of Medicine, Konkuk University, Chungju, Korea.
- Publication Type:Original Article
- Keywords:
Cancinoma, non-small cell, lung;
Neoplasm metastasis;
Mediastinal lymph nodes;
Neoplasm staging
- MeSH:
Carcinoma, Non-Small-Cell Lung*;
Drug Therapy;
Esophagus;
Heart;
Humans;
Korea;
Lung;
Lung Neoplasms;
Medical Records;
Mortality;
Neoadjuvant Therapy;
Neoplasm Metastasis;
Neoplasm Staging;
Pneumonectomy;
Retrospective Studies;
Vagus Nerve
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2004;37(4):349-355
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Non-small cell lung cancer (NSCLC) with invasion of mediastinal structures is classified as stage IIIB, and has been considered surgically unresectable. However, in a selected group of these patients, better results after surgical resection compared to non-surgical group have been reported. The aim of this study is to evaluate the role of surgical resection in treatment of mediastinal T4 NSCLC. MATERIAL AND METHOD: Among 1067 patients who underwent surgical intervention for non-small cell lung cancer from Aug 1987 to Dec 2001 in Korea cancer center hospital, 82 patients had an invasion of T4 mediastinal structures (7.7%). Resection was possible in 63 patients (63/82 resectability 76.8%). Their medical records in Data Base were reviewed, and they were followed up completely until Jun 2002. Surgical results and prognostic factors of NSCLC invading mediastinal structures were evaluated retrospectively. RESULT: Lung cancer was resected completely in 52 patients (63.4%, 52/82). Lung resection was lobectomy (or more) in 14, pneumonectomy in 49. The mediastinal structures invaded by primary tumor were great vessel (61.9%), heart (19%), vagus nerve (9.5%), esophagus (7.9%), and vertebral body (7.9%). Nodal status was N0 in 11, N1 in 24, and N2 in 28 (44.4%). Neoadjuvant therapy was done in 6 (9.5%, 5 chemotherapy, 1 radiotherapy), and adjuvant therapy was added in 44 (69.8%, 15 chemotherapy, 29 radiotherapy) in resection group (n=63). Complication was occurred in 23 (31.7%), and operative mortality was 9.5% in resection group. Median and 5 year overall survival including operative mortality was 18.1 months and 21.7% in resection group (n=63), 6.2months and 0 % in exploration only group (n=19, p=.001), 39 months and 32.9% in N2 (-) resection group (n=35), and 8.8 months and 8.6% in N2 (+) resection group (n=28, p=.007). The difference of overall survival by mediastinal structure was not significant. CONCLUSION: The operative risk of NSCLC invading mediastinal structures was high but acceptable, and long-term result of resection was favorable in selected group. Aggressive resection is recommended in well selected pateints with good performace and especially N2 (-) NSCLC with mediastinal invasion.
